Stereotactic ablative body radiation therapy (SABR) in NSW

被引:0
作者
Elizabeth R. Claridge Mackonis
Nicholas Hardcastle
Annette Haworth
机构
[1] Chris O’Brien Lifehouse,Department of Radiation Oncology
[2] University of Sydney,School of Physics
[3] Peter MacCallum Cancer Centre,Physical Sciences
来源
Physical and Engineering Sciences in Medicine | 2020年 / 43卷
关键词
SABR; SBRT; Stereotactic body radiation therapy; NSW; Survey;
D O I
暂无
中图分类号
学科分类号
摘要
A survey was conducted to establish the current utilisation of stereotactic ablative radiation therapy (SABR) services in NSW. The objective of the survey was to generate baseline data to inform requirements for a networked approach to the implementation of new radiation therapy techniques and technologies. All radiation therapy services in NSW were contacted by email with a request to complete a SABR service survey. Questions were designed to identify equipment used, treatment techniques in place, clinical sites treated with a SABR technique and plans to expand the current services offered. Each professional group was asked to identify areas of service delivery they would most like to improve. Sixteen responses were received representing 24 of 27 (89%) of NSW radiation therapy centres. The results indicate that most centres now treat with SABR, however the number of centres and the treatment sites are still increasing. VMAT treatments and 3D imaging are now commonplace. Liver was the most commonly reported treatment site where confidence in service delivery needed improvement. Data from the survey will be useful in formulating future collaborative and educational activities aimed at improving safety and efficacy in SABR service delivery to all patients in NSW and potentially the rest of the country.
引用
收藏
页码:641 / 650
页数:9
相关论文
共 367 条
[1]  
Uematsu M(1998)Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience Cancer 82 1062-1070
[2]  
Shioda A(2009)Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients Acta Oncol 34 861-870
[3]  
Tahara K(2009)Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 677-682
[4]  
Fukui T(2017)ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer Radiother Oncol 124 11-17
[5]  
Yamamoto F(2018)Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial Int J Radiat Oncol Biol Phys 102 S3-S4
[6]  
Tsumatori G(2018)Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy Radiother Oncol 128 274-282
[7]  
Ozeki Y(2018)Multicenter trial of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer: survival and toxicity endpoints Int J Radiat Oncol Biol Phys 102 296-303
[8]  
Aoki T(2018)ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial Radiat Oncol 13 166-212
[9]  
Watanabe M(2017)Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial BMC Cancer 17 180-533
[10]  
Kusano S(2018)Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): a phase 2 randomized trial Radiother Oncol 127 206-301